An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing β-galactosidase: Evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization
- 1 August 1992
- Vol. 189 (2), 629-639
- https://doi.org/10.1016/0042-6822(92)90586-e
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopesVaccine, 1991
- BHV-1 Adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surfaceVirology, 1991
- Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cellsJournal of General Virology, 1991
- Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous systemVirus Research, 1988
- Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.The Journal of Experimental Medicine, 1987
- Bovine herpesvirus type 1 gp87 mediates both attachment of virions to susceptible cells and hemagglutinationArchiv für die gesamte Virusforschung, 1987
- Intramuscular and intravaginal vaccination of pregnant cows with thymidine kinase-negative, temperature-resistant infectious bovine rhinotracheitis virus (bovine herpes virus 1)Vaccine, 1986
- Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cellsNature, 1984
- Cellular Aspects of Immunoglobulin AAdvances in Immunology, 1976